170 related articles for article (PubMed ID: 3081647)
21. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
James SL; Correa-Oliveira R; Leonard EJ
J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002
[TBL] [Abstract][Full Text] [Related]
22. Adoptive transfer of protective immunity in experimental schistosomiasis in the mouse.
Maddison SE; Kagan IG
J Parasitol; 1979 Aug; 65(4):515-9. PubMed ID: 512748
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni.
Wynn TA; Oswald IP; Eltoum IA; Caspar P; Lowenstein CJ; Lewis FA; James SL; Sher A
J Immunol; 1994 Dec; 153(11):5200-9. PubMed ID: 7525727
[TBL] [Abstract][Full Text] [Related]
24. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.
Pemberton RM; Wilson RA
Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008
[TBL] [Abstract][Full Text] [Related]
25. Schistosoma mansoni: IgG reactivity to soluble adult worm antigen preparation (SWAP) in sera of immunized mice with irradiated attenuated and virulent cercariae.
Hanna LS; Mohamed MI; Botros SS
J Egypt Soc Parasitol; 1994 Dec; 24(3):553-68. PubMed ID: 7844419
[TBL] [Abstract][Full Text] [Related]
26. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
27. Immunoprecipitation analysis of radiolabelled protein antigens biosynthesized in vitro by S. mansoni. I. Identification of antigens uniquely recognized by protective antibodies.
Barker RH; Srivastava BS; Suri P; Goldberg M; Knopf PM
J Immunol; 1985 Feb; 134(2):1192-201. PubMed ID: 3965570
[TBL] [Abstract][Full Text] [Related]
28. The presence of antibody in mice chronically infected with Schistosoma mansoni which blocks in vitro killing of schistosomula.
Yi XY; Simpson AJ; de Rossi R; Smithers SR
J Immunol; 1986 Dec; 137(12):3955-8. PubMed ID: 3097137
[TBL] [Abstract][Full Text] [Related]
29. Identification of Schistosoma mansoni glycoproteins recognized by protective antibodies from mice immunized with irradiated cercariae.
Dalton JP; Strand M; Mangold BL; Dean DA
J Immunol; 1986 Jun; 136(12):4689-94. PubMed ID: 3086439
[TBL] [Abstract][Full Text] [Related]
30. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
James SL; Pearce EJ; Sher A
J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement.
Sher A; Hieny S; James SL; Asofsky R
J Immunol; 1982 Apr; 128(4):1880-4. PubMed ID: 6801124
[TBL] [Abstract][Full Text] [Related]
32. Defective vaccine-induced resistance to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity.
James SL; Deblois LA; Al-Zamel F; Glaven J; Langhorne J
J Immunol; 1986 Dec; 137(12):3959-67. PubMed ID: 3097138
[TBL] [Abstract][Full Text] [Related]
33. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
[TBL] [Abstract][Full Text] [Related]
34. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia.
Wynn TA; Jankovic D; Hieny S; Cheever AW; Sher A
J Immunol; 1995 May; 154(9):4701-9. PubMed ID: 7722323
[TBL] [Abstract][Full Text] [Related]
35. Maternal transfer of resistance to Schistosoma mansoni.
Knopf PM; Coghlan RL
J Parasitol; 1989 Jun; 75(3):398-404. PubMed ID: 2498494
[TBL] [Abstract][Full Text] [Related]
36. Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of Schistosoma mansoni.
Richter D; Reynolds SR; Harn DA
J Immunol; 1993 Jul; 151(1):256-65. PubMed ID: 8326127
[TBL] [Abstract][Full Text] [Related]
37. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
Hoffmann KF; James SL; Cheever AW; Wynn TA
J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
[TBL] [Abstract][Full Text] [Related]
38. Immunostimulatory effect of coumarin derivatives before and after infection of mice with the parasite Schistosoma mansoni.
Maghraby A; Bahgat M
Arzneimittelforschung; 2004; 54(9):545-50. PubMed ID: 15500201
[TBL] [Abstract][Full Text] [Related]
39. Protection against Schistosoma mansoni achieved by immunization with sonicated parasite.
Horowitz S; Smolarsky M; Arnon R
Eur J Immunol; 1982 Apr; 12(4):327-32. PubMed ID: 6178604
[TBL] [Abstract][Full Text] [Related]
40. Protection of mice against Schistosoma mansoni infection by passive transfer of sera from infected rabbits.
Fallon PG; Fookes RE; Doenhoff MJ
Parasite Immunol; 1996 Jan; 18(1):7-14. PubMed ID: 9223151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
